Analysis of PSPHL as a candidate gene influencing the racial disparity in endometrial cancer

Jay E. Allard, Gadisetti V.R. Chandramouli, Katherine Stagliano, Brian L. Hood, Tracy Litzi, Yutaka Shoji, Jeff Boyd, Andrew Berchuck, Thomas P. Conrads, G. Larry Maxwell, John I. Risinger*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

22 Scopus citations


Endometrial cancer is the most commonly diagnosed gynecologic malignancy in the United States. A well recognized disparity by race in both incidence and survival outcome exists for this cancer. Specifically Caucasians are about two times more likely to develop endometrial cancer than are African-Americans. However, African-American women are more likely to die from this disease than are Caucasians. The basis for this disparity remains unknown. Previous studies have identified differences in the types and frequencies of gene mutations among endometrial cancers from Caucasians and African-Americans suggesting that the tumors from these two groups might have differing underlying genetic defects. We performed a gene expression microarray study in an effort to identify differentially expressed transcripts between African-American and Caucasian women's endometrial cancers. Our gene expression screen identified a list of potential biomarkers that are differentially expressed between these two groups of cancers. Of these we identified a poorly characterized transcript with a region of homology to phospho serine phosphatase (PSPH) and designated phospho serine phosphatase like (PSPHL) as the most differentially over-expressed gene in cancers from African-Americans. We further clarified the nature of expressed transcripts. Northern blot analysis confirmed the message was limited to a transcript of under 1 kB. Sequence analysis of transcripts confirmed two alternate open reading frame (ORF) isoforms due to alternative splicing events. Splice specific primer sets confirmed both isoforms were differentially expressed in tissues from Caucasians and African-Americans. We further examined the expression in other tissues from women to include normal endometrium, normal and malignant ovary. In all cases PSPHL expression was more often present in tissues from African-Americans than Caucasians. Our data confirm the African-American based expression of the PSPHL transcript in endometrial cancer and also identify its expression in other tissues from African-Americans including ovary and ovarian cancer. PSPHL represents a candidate gene that might influence the observed racial disparity in endometrial and other cancers.

Original languageEnglish
Article numberArticle 65
JournalFrontiers in Oncology
Volume2 JUL
StatePublished - 2012
Externally publishedYes


  • Endometrial cancer
  • Racial disparity


Dive into the research topics of 'Analysis of PSPHL as a candidate gene influencing the racial disparity in endometrial cancer'. Together they form a unique fingerprint.

Cite this